Eddingpharm looks to build alliances, R&D and overseas presence
This article was originally published in Scrip
Executive Summary
Cross-border licensing deals have often been used by foreign drug companies as a relatively easy way to get into China, the main requirements being to find a knowledgeable, experienced and well connected local partner.